Copperwynd Financial, LLC Acer Therapeutics Inc. Transaction History

Copperwynd Financial, LLC

  • $330 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$1.28 - $1.6 $29,766 - $37,208
23,255 Added 100.0%
46,510 $65,000
Q2 2022

Aug 05, 2022
BUY
$1.19 - $3.04 $27,673 - $70,695
23,255 New
23,255 $29,000

Others Institutions Holding ACER

# of Institutions
1
Shares Held
365
Call Options Held
0
Put Options Held
0
View Full List

About Acer Therapeutics Inc.

ACER Quotes by TradingView
  • Ticker ACER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,100,000
  • Description
  • Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...
More about ACER
Track This Portfolio

Track Copperwynd Financial, LLC Portfolio

Follow Copperwynd Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email